# COVID-19 治疗相关报道

### 疫情地图

-[Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering](https://coronavirus.jhu.edu/map.html)

-[Novel coronavirus (COVID-19) outbreak timeline map](https://www.healthmap.org/covid-19/)

-[Novel coronavirus infection map](https://hgis.uw.edu/virus/)

-[Novel coronavirus (COVID-19) situation dashboard (WHO)](https://who.maps.arcgis.com/apps/opsdashboard/index.html#/c88e37cfc43b4ed3baf977d77e4a0667)

-[Coronavirus: the new disease Covid-19 explained](https://multimedia.scmp.com/infographics/news/china/article/3047038/wuhan-virus/index.html?src=article-launcher)

-[全球新冠病毒最新实时疫情地图_丁香园](https://ncov.dxy.cn/ncovh5/view/pneumonia)

-[北美版丁香园 美国和加拿大 疫情地图实时动态追踪](https://coronavirus.1point3acres.com/)

## 检测试剂

- [2020-03-17 中美上市新型冠状病毒检测试剂对比](https://mp.weixin.qq.com/s?__biz=MzA3ODgzODc5NA==&mid=2651778806&idx=1&sn=241867507717156503d81c7694487f57&chksm=8446e393b3316a856f0b8e5381f13d5b7a401e776b92af57c075d2d71c807d7be6a3721c5280&mpshare=1&scene=1&srcid=0318xetmhIcbKxoRNtN4AmfM&sharer_sharetime=1584492582044&sharer_shareid=a95d81bba82caa939c92c4c89cf532d1&exportkey=Anhhsami5IaqdwlUjPVAtbE%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)
![对比](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/shiji1.jpg)

## 治疗方案

## 疫苗相关／新药开发

- [2020-03-16 重磅|康希诺生物新冠疫苗进入临床试验招募阶段！](https://mp.weixin.qq.com/s?__biz=MzI4OTIzMzcwMw==&mid=2659320076&idx=2&sn=50075531d1b58f676ac3dab8444861a5&chksm=f744ef44c03366523e5f4dbb0d527405e35f485d7345bc067ecae68c1feee4732d700728c069&mpshare=1&scene=1&srcid=0318yCwSHpA56JZwEOlr3J3G&sharer_sharetime=1584492754342&sharer_shareid=a95d81bba82caa939c92c4c89cf532d1&exportkey=Avu9z%2FuymCwRdFmhBHGGydY%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)

- [2020-03-17 康希诺生物全国首款重组新型冠状病毒疫苗获批进入临床](https://mp.weixin.qq.com/s?__biz=MzI0Nzc5MDU4OQ==&mid=2247483963&idx=1&sn=5511849497d6e65abf843780068b17e5&chksm=e9abeca9dedc65bf03d7a59ff57d33eb5178350db36f32b4b02d8bd727d36f6d240dee50e785&mpshare=1&scene=1&srcid=&sharer_sharetime=1584496562702&sharer_shareid=a95d81bba82caa939c92c4c89cf532d1&exportkey=Alcx7stNO%2Fwzud2qt%2FhA0Po%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)
![康希诺](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/kangxinuo.jpg)


- [2020-03-17 再生元已鉴定数百种新冠病毒中和抗体，有望下月进入临床](https://mp.weixin.qq.com/s?__biz=MzI5OTAyOTI1Ng==&mid=2247483964&idx=1&sn=dc16f2998761ee4fd400a3cb1bf5b12f&chksm=ec9d845bdbea0d4daca5ecfc9a7e2580c7e9f506aa8c2965b419c492fca526a835535d5ed745&mpshare=1&scene=1&srcid=&sharer_sharetime=1584495733288&sharer_shareid=a95d81bba82caa939c92c4c89cf532d1&exportkey=ApHWUQi7gxVafMZZ1HF1vyE%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)
![再生元](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/zaishengyuan.jpg)

- [2020-03-17 我国疫苗研发属于国际先进行列，不会慢于国外](https://news.html5.qq.com/share/1237309093773132098?cardmode=1&ch=060000&dataSrc=96&docId=1237309093773132098&from=timeline&isappinstalled=0&pid=1&qbredirect=&queryId=1584434838014&sc_id=7OqxzeD&sh_sid=5__25bda8df21827333__a7f844b04b6a4ecb13644c6913b788cb&share=true&share_count=2&subjectId=12307&url=http%3A%2F%2Fkuaibao.qq.com%2Fs%2F20200317A0ISG200&zimeitiId=qeh_5109679)
![慢](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/man.jpg)

- [2020-03-17 重磅！军队成功研制重组新冠疫苗](http://www.mod.gov.cn/topnews/2020-03/17/content_4862066.htm?from=timeline&isappinstalled=0)
![军队](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/jun.jpg)

- [2020-03-17 中美德mRNA新冠疫苗研发竞赛，中国何时用上？](https://news.html5.qq.com/share/5984103083725543746?cardmode=1&ch=060000&dataSrc=96&docId=5984103083725543746&from=timeline&isappinstalled=0&pid=1&qbredirect=&queryId=1584435537021&sc_id=dfjJNuD&sh_sid=5__25bda8df21827333__a7f844b04b6a4ecb13644c6913b788cb&share=true&share_count=2&subjectId=1041601&url=http%3A%2F%2Fkuaibao.qq.com%2Fs%2F20200317A0E8ZO00&zimeitiId=qeh_1654)
![复星](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/fuxing.jpg)

- [2020-03-16 上海市科委：新冠疫苗已启动灵长类动物实验，预计4月中旬临床试验](https://mp.weixin.qq.com/s?__biz=MjI3Njc0NTk4MQ==&mid=2649979424&idx=3&sn=5810764fca37c1f1326c9b4cdf6a8cff&chksm=b78c4fb280fbc6a4a541f821db1cb9ce729b0b9a112ab78e8d3c1fc31b8ecb4d461d6e32889e&mpshare=1&scene=1&srcid=0317gT6mROiqrILCZesHpjud&sharer_sharetime=1584496435992&sharer_shareid=a95d81bba82caa939c92c4c89cf532d1&exportkey=AsQnPZqQHDiDeTIprPkzoMU%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)
![上海](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/dongwu.jpg)

## 研究进展

- [2020-03-17 上海交大等多个团队联合研究发现：A型血的人更易感染新冠病毒，O型血最不易感染！](https://mp.weixin.qq.com/s?__biz=MzIwMzA1MzU5Mg==&mid=2652139183&idx=1&sn=3f40e20e154d49f18e77220f8f6d497f&chksm=8d3581d8ba4208ceb1e2fc0e4f9d6c99d0feca5ab5255b503a3cc428c19482efbb796526b92b&mpshare=1&scene=1&srcid=&sharer_sharetime=1584494317607&sharer_shareid=1276c91aef12fcece8d6cc480b1cfdf0&exportkey=AjJ6hto0PQAQmJeSn6l%2Bpdo%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)
![A型](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/atype.jpg)

## 典型病历史报道

-[2020-03-17 Coronavirus Study: One Traveler from China Infected 39 People in Washington State](https://www.breitbart.com/health/2020/03/17/wuhan-report-one-traveller-from-china-infected-39-people-in-washington-state/)

-[2020-03-16 《柳叶刀》：如何遏制社区传播？新加坡复盘3起“跨国”聚集性疫情](https://mp.weixin.qq.com/s?__biz=MzAxOTU2OTU4MQ==&mid=2649914415&idx=1&sn=36960f74162441fa1cf6cb18217ea4b3&chksm=83c3d2edb4b45bfb9d8ecac035cd827afe5824335133ad2618871939b3857cc09158bf67e609&mpshare=1&scene=1&srcid=&sharer_sharetime=1584496724592&sharer_shareid=a95d81bba82caa939c92c4c89cf532d1&exportkey=Ajvk8j0FhYRgYjsPTL3vJSA%3D&pass_ticket=Ym0fpwqfCHTJOr2fhlHchYZ8NaqDH4zPzxIH4YkaW0zpdzFeWiSxEe6AgNZ1RNSD#rd)

## 其他

- [2020-03-13 COVID-19 Open Research Dataset Challenge (CORD-19)](https://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge?from=timeline&isappinstalled=0)
![kaggle](https://github.com/fengqifang/CURE-COVID-19/blob/master/pic/kaggle.jpg)
